Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics

Clinical trial NCT02430545 · COMPLETED

Trial details

NCT number: NCT02430545
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2015-05-01
Primary completion: 2015-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.